CO

Sinco Pharma is the fourth largest marketing, promotion and channel management service provider in the PRC pharmaceutical industry with a market share of 4.2% in terms of revenue for 2016. We are also the only marketing, promotion and channel management service provider for plasma-based pharmaceuticals. The plasma-based pharmaceuticals market in China grew at a CAGR of 25.4% from 2012 to 2016. It is expected to reach RMB98.14 billion in 2021, representing a CAGR of 26.1% from 2017. China's human albumin market grew rapidly at a CAGR of 22.2%, and is expected to grow at a CAGR of 22.8% from 2017 to 2021... According to Frost Sullivan, we are the third largest supplier of marketing, promotion and channel management services in the pharmaceutical industry in China, with a market share of 6.4%.

Also known as: Co., Ltd

Primary location: Chengdu China